COMPARATIVE INVITRO ACTIVITY OF LY146032 (DAPTOMYCIN), A NEW LIPOPEPTIDE ANTIMICROBIAL

被引：19
作者：
HODINKA, RL
JACKWAIT, K
WANNAMAKER, N
WALDEN, TP
GILLIGAN, PH
机构：
[1] UNIV N CAROLINA,SCH MED,DEPT PATHOL,CHAPEL HILL,NC 27514
[2] UNIV N CAROLINA,SCH MED,DEPT MICROBIOL IMMUNOL,CHAPEL HILL,NC 27514
来源：
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 1987年 / 6卷 / 01期
关键词：
D O I：
10.1007/BF02097211
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：100 / 103
页数：4
相关论文
共 7 条
[1]   INVITRO AND INVIVO ACTIVITY OF LY 146032, A NEW CYCLIC LIPOPEPTIDE ANTIBIOTIC [J].
ELIOPOULOS, GM ;
WILLEY, S ;
REISZNER, E ;
SPITZER, PG ;
CAPUTO, G ;
MOELLERING, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (04) :532-535
[2]   INVITRO ACTIVITY AND MECHANISM OF ACTION OF A21978C1, A NOVEL CYCLIC LIPOPEPTIDE ANTIBIOTIC [J].
ELIOPOULOS, GM ;
THAUVIN, C ;
GERSON, B ;
MOELLERING, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (03) :357-362
[3]   INVITRO ACTIVITY OF LY146032 AGAINST STAPHYLOCOCCI, STREPTOCOCCI, AND ENTEROCOCCI [J].
FASS, RJ ;
HELSEL, VL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (05) :781-784
[4]   ISOLATION OF CLOSTRIDIUM-DIFFICILE FROM THE ENVIRONMENT AND CONTACTS OF PATIENTS WITH ANTIBIOTIC-ASSOCIATED COLITIS [J].
KIM, KH ;
FEKETY, R ;
BATTS, DH ;
BROWN, D ;
CUDMORE, M ;
SILVA, J ;
WATERS, D .
JOURNAL OF INFECTIOUS DISEASES, 1981, 143 (01) :42-50
[5]  
MAKI DG, 1982, CURRENT CLIN TOPICS, V3, P309
[6]   METHOD FOR RELIABLE DETERMINATION OF MINIMAL LETHAL ANTIBIOTIC CONCENTRATIONS [J].
PEARSON, RD ;
STEIGBIGEL, RT ;
DAVIS, HT ;
CHAPMAN, SW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (05) :699-708
[7]  
Washington J.A., 1980, MANUAL CLIN MICROBIO, P453
1